More information: Agnieszka Krzyzanowska et al, Clinical validation of a biopsy‐based six‐gene signature prognostic for aggressive prostate cancer, BJUI Compass (2024). DOI: 10.1002/bco2.474 ...
PESG Research releases an update following groundbreaking clinical evaluation results: Inspira Technologies* (NASDAQ: IINN) ...
RNA sequencing has emerged as a powerful supplement to DNA sequencing for Mendelian disease diagnosis, but clinical translation of diagnostic RNA-seq has not been widely achieved. Researchers at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback